To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Gene therapy for head and neck cancer, and clinical trials in head and neck cancer.
Head and Neck Oncology- Melanoma/Skin
The 2022 Hour Detroit’s Top Docs List is out and 35 physicians from Barbara Ann Karmanos Cancer Institute are named top doctors under 20 different specialties. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan (Wayne, Oakland, Macomb, Washtenaw and Livingston Counties). Participating physicians in the aforementioned counties are asked to nominate a doctor who they view ...
As it’s known that lung cancer can be a secondary cancer following a head and neck cancer, multiple oncologists and researchers at Karmanos contributed to a study that takes a look at the risk level among African American patients compared to White patients. Their study titled, “African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer,” will be published in Head & Neck. The contributing Karmanos specialists and researchers are: Am...
The Cancer Letter George Yoo, M.D., FACS , Chief Medical Officer at the Barbara Ann Karmanos Cancer Institute, discusses the ways that Karmanos adapted to telehealth during 2020 and offers strategies that can be used by other cancer centers. Click here to read the complete article. Click here to download a PDF of the article.